Purchase Order HHSN272201400161P

The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,657.20 firm fixed-price purchase order to Ebioscience, Inc., a subsidiary of Affymetrix, Inc., for the supply of monoclonal antibodies, including shipping charges. The contract, which does not have a set-aside designation, was awarded on September 11, 2011, with a completion date of September 19, 2012. This standing order is likely part of NIAID's broader efforts to...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...

The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a $19,030.96 firm fixed-price purchase order to Epitomics Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of antibodies. The award, which was not set aside, has an ultimate completion date of April 28, 2014. This purchase order is associated with Epitomics' quote number CSQ_3719. No further details about a larger contract vehicle or...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Ebioscience, Inc., a subsidiary of Affymetrix, Inc. The contract is for the delivery of antibodies with a ceiling value of $4,825.50. The award was made on July 21, 2014, with a completion date of July 25, 2014. The contract was not set aside for any specific business type. This award appears to be part of NIAID's broader efforts to procure various reagents and supplies for...

<p>The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Biolegend, Inc. for antibodies with a ceiling value of $12,042.50 on September 2, 2020, with an ultimate completion date of October 2, 2020. No set-aside was used. Performance takes place in San Diego, California. The order is firm fixed price for commercial antibody products supplied by Biolegend, a biomedical reagents manufacturer.</p>

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) to Pacific Immunology, a U.S. biotech company located in Ramona, California. The $4,436.81 contract is for the production and delivery of monospecific antibodies and related services to support biomedical research. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of NIH, and does not utilize a small business set-aside. The services to...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...

This contract award, with ID HHSN272201400892P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Aalto Bio Reagents LIMITED, a for-profit limited liability company. The $3,935.00 firm fixed-price contract is for the purchase of an unspecified antibody product, with a completion date of September 15, 2014. The contract did not utilize any set-aside designations. Without additional information on the original...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biolegend, Inc. valued at $6,892.26 on August 9, 2018, for antibodies. The order was issued as a firm fixed-price acquisition with no set-aside. Place of performance is San Diego, California. The ultimate completion date is August 8, 2019. The purchase order was issued to de-obligate expiring FY'18 funds.</p>